Journal of Immunogenetics. Vol. I No. 1. Jan. 1974 . Edited by K. Bauer. Published by Blackwell Scientific Publications. Growing points in medicine tend to occur mainly at the interfaces between disciplines and part of the phenomenon is the generation of " in groups ". Since by definition we are all out of most "in groups ", keeping up to date is often impossible and one can easily overlook quite important developments. In oncology, for example, relevant articles appear in specialist journals devoted to radiobiology, pharmacology, virology, immunology and genetics while clinical journals carry many articles of oncological interest. Abstracting services provide a partial solution to the problem of getting up to date, but paradoxically the appearance of new specialist journals covering contiguous areas of classic studies may be of great value. Such is perhaps the case with immunogenetics, a subject which involves antigenic polymorphisms and has recently come of age in studies of the genetic control of immune responsiveness and of antibody structure. There is much of interest in immunology and in genetics to cancer studies, particularly the antigenicity of tumours and the ability of the host to respond to them. The immunological and genetic interactions between oncogenic viruses, host genotypes, somatic mutations and environmental mutagens are, with cell kinetics and the genetic control of differentiation, areas of great interest in fundamental oncological research.
In his editorial introduction to Volume I, 
E1tirowtmental carcinoyenesis
Newcombe advocates the use of new comiiputer technology for the complete prospective recording of the population of a proviince or even nation as the basis for epidemiological studies. Koestner presents evidence of transplacental carcinogenesis in the rat with MNU and ENU. Stich et al., in a general account of DNA repair processes, advocate their use to detect carcinogens, but the rate of repair of DNA is equally dependent on the amount of damage sustained and the efficiency of repair processes. Thus, for a knowNn carcinogen, the amount of DNA repair would be inversely related to the carcinogenicity.
Tunmour immunoloyy
This topic is favoured writh t,wo cliniical papers. Lewis has studied autologous antibodies in melanoma. He concludes that their presence delays metastasis and they are therefore the key to the control of the disease. Powles gives the shortest paper in the conference but it is probably the one of the greatest interest to clinicians. It describes the prolongation of remission (not cure) of myelogenous leukaemia by stimulating the patients' immune response with a combination of B.C.G. and irradiated allogeneic mnyeloblastic leukaemic cells. Prehn airs his scepticism of immunological surveillance as the natural method of controlling cancer. He avers that the patients' immune response to a tumour is both too little and too Iate.
Chemotherapy
Hall argues for a more scientific approach to the selection of chemicals and particularly of combinations of chemicals for clinical use. Bruce criticizes the criterion of size alone as a measure of the response of an animal tumnour to treatment and recommends the use of transplantability also as a measure of its viability. LePage describes successes in chemotherapy by a combination of a sophisticated thioguanine derivative (/l-2'-deoxythioguanosine) and cytosine arabinoside.
This slim volume is luxuriously produced and expensive. It is no doubt a boost to the morale of Canadian cancer research (though half of the 12 papers are from nonCanadian laboratories). One would expect most of the material to appear elsewhere before or after the conference. It is doubtful therefore whether it makes a w%orthwhile contribution to the wNorld literature on cancer research.
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